1 min read
Add as a preferred source on GoogleLyell Immunopharma Agrees to $80 Million Private Placement
The agreement prices about 7.43 million common shares at $10.77 each. The transaction was expected to close around Nov. 4, 2026.
Lyell Immunopharma, Inc. (LYEL) agreed to issue about 7.43 million common shares in a private placement expected to raise about $80 million if it closes.
The agreement sets the sale price at $10.77 per share. The expected proceeds are not a completed raise; they depend on the placement closing.
The transaction was expected to close around Nov. 4, 2026.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.